CN103784888A - Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis - Google Patents
Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis Download PDFInfo
- Publication number
- CN103784888A CN103784888A CN201410059637.8A CN201410059637A CN103784888A CN 103784888 A CN103784888 A CN 103784888A CN 201410059637 A CN201410059637 A CN 201410059637A CN 103784888 A CN103784888 A CN 103784888A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis. The traditional Chinese medicine is prepared from the following components: the roots of red-rooted salvia, astragalus membranaceus, corydalis tubers, ligusticum wallichii, radix curcumae, radix ophiopogonis, caulis spatholobi, hawthorn, turmeric, ginseng, rhizoma sparganii, saffron crocus, roots of common peony, sealwort, cassia twig, pericarpium citri reticulatae, liquorice, angelica sinensis, cistanche, lignum dalbergiae odoriferae, rhodiola rosea, rhizoma acori graminei, trogopterus dung, radix polygonati officinalis, pseudo-ginseng, rheum officinale and borneol. The excellent efficiency is close to 100%, and the cure rate is about 90%.
Description
Technical field
The present invention relates to one and treat atherosclerotic Chinese patent medicine, the Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease.
Background technology
Blood stasis due to qi deficiency is the one of the Chinese medical discrimination type of coronary atherosclerotic heart disease, is also the most common one.The medicine of existing atherosclerotic heart disease is generally effective to this type of cardiovascular disease, as Heart pill of Musk, Nuodikang oral liquid etc.Existing patent documentation discloses this atherosclerotic Chinese patent medicine of some treatments.Below list the closely-related partial monopoly document with the application.
201110453345.9 relate to a kind of Chinese medicine composition for the treatment of angina pectoris, and it comprises Radix Codonopsis, the Radix Astragali, Fructus Mori, Rhizoma Chuanxiong, Radix Curcumae, Oletum Trogopterori, Flos Rosae Rugosae, Semen Litchi and Lignum Aquilariae Resinatum.This Chinese medicine composition is mainly used in treating coronary heart disease with qi deficiency and blood stasis, and the compatibility relationship of Radix Codonopsis and Oletum Trogopterori it be unclear that.
201110388238.2 relate to treatment coronary heart disease with qi deficiency and blood stasis anginal Chinese medicine preparation, are made up of the raw material of Chinese medicine of following parts by weight: 2 parts of 3 parts of Radix Ginsengs, 2 parts of Rhizoma Chuanxiongs, 2 parts of Caulis Spatholobis, 2 parts of Rhizoma Acori Graminei, 3 parts of Fructus Crataegis and Herba Leonuris.Radix Ginseng can strongly invigorating primordial QI, and Rhizoma Chuanxiong can blood-activating and qi-promoting, wind-expelling pain-stopping, Caulis Spatholobi for promoting the circulation of blood enrich blood, relaxing muscles and tendons and activating QI and blood in the collateral, Rhizoma Acori Graminei can resuscitation inducing and mind tranquilizing, Fructus Crataegi is for circulation of qi promoting dissipating blood stasis.
201110288916.8(102319401B) disclose a kind of Chinese medicine composition for benefiting QI for activating blood circulation, spleen invigorating dredging collateral, this Chinese medicine composition is made up of the Radix Astragali, Radix Salviae Miltiorrhizae, Herba Cistanches, Radix Curcumae, Rhizoma Chuanxiong, Fructus Crataegi, Rhizoma Polygonati, Semen Ginkgo, Radix Et Rhizoma Rhei and Pheretima.Herba Cistanches, Rhizoma Polygonati can be controlled syndrome of blood stasis due to qi deficiency.
201110201859.5(102293985B) be used for the treatment of the Chinese medicine composition of coronary heart disease, it comprises: the Pericarpium Citri Reticulatae of 10～12 weight portion Radixs Astragali, 10～12 weight portion Radix Salviae Miltiorrhizaes, 8～10 weight portion Rhizoma Chuanxiongs, 6～8 weight portion Radix Notoginseng, 10～12 weight portion Rhizoma Curcumae Longaes, 4～6 weight portion Rhizoma Pinelliae Preparatum, 3～5 weight portions, 2～4 weight portion Fructus Piperis Longi.This case claims to have in Pericarpium Citri Reticulatae the compositions such as the limonene, α-thujene, beta-myrcene of the function of invigorating spleen that reduces phlegm to exist with volatile oil form, can assist monarch drug treatment blood stasis due to qi deficiency phlegm retention coronary heart disease after proposition.
200910057608.7(101953890B) relate to a kind of Chinese medicine composition for the treatment of coronary heart disease heart failure, crude drug by following weight ratio is made: the Radix Astragali 19.35～63.16%, Radix Rhodiolae 4.65～20.34%, Lignum Dalbergiae Odoriferae 14.63～46.15%, Radix Stephaniae Tetrandrae 7.5～29.03% and Cortex Cinnamomi 1.64～15%.Radix Rhodiolae, Lignum Dalbergiae Odoriferae contribute to treat qi depression to blood stasis.
The curative effect of the prescription of prior art is limited, requires further improvement.
Summary of the invention
For solving the problem of prior art, the invention provides a kind of Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease.This Chinese medicine composition is according to the feature of gas Qi deficiency blood stasis type coronary atherosclerosis, the important component such as the reasonable compatibility Radix Astragali, Radix Notoginseng, Radix Salviae Miltiorrhizae, Radix Ginseng and Oletum Trogopterori, and reaching has no side effect treats coronary atherosclerotic heart disease.
A kind of Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that, according to the mass fraction, consist of the following composition: 250 ~ 265 parts of Radix Salviae Miltiorrhizaes, 250 ~ 260 parts of the Radixs Astragali, 135 ~ 145 parts of Rhizoma Corydalis, 135 ~ 145 parts of Rhizoma Chuanxiongs, 135 ~ 140 parts of Radix Curcumaes, 125 ~ 130 parts of Radix Ophiopogonis, 120 ~ 129 parts of Caulis Spatholobis, 120 ~ 129 parts of Fructus Crataegis, 120 ~ 125 parts, Rhizoma Curcumae Longae, 120 ~ 125 parts of Radix Ginsengs, 105 ~ 110 parts of Rhizoma Sparganii, 105 ~ 110 parts of Stigma Crocis, 105 ~ 110 parts of Radix Paeoniae Rubra, 90 ~ 110 parts of Rhizoma Polygonatis, 90 ~ 100 parts of Ramulus Cinnamomi, 86 ~ 90 parts of Pericarpium Citri Reticulataes, 86 ~ 89 parts, Radix Glycyrrhizae, 86 ~ 89 parts of Radix Angelicae Sinensis, 86 ~ 89 parts of Herba Cistanches, 80 ~ 90 parts of Lignum Dalbergiae Odoriferaes, 80 ~ 90 parts of Radix Rhodiolaes, 80 ~ 85 parts of Rhizoma Acori Graminei, 65 ~ 70 parts of Oletum Trogopteroris, 55 ~ 60 parts of Rhizoma Polygonati Odorati, 55 ~ 60 parts of Radix Notoginseng, 40 ~ 45 parts of Radix Et Rhizoma Rhei, 8 ~ 10 parts of Borneolum Syntheticums.
As preferably: 260 parts of Radix Salviae Miltiorrhizaes, 250 parts of the Radixs Astragali, 135 parts of Rhizoma Corydalis, 145 parts of Rhizoma Chuanxiongs, 135 parts of Radix Curcumaes, 130 parts of Radix Ophiopogonis, 125 parts of Caulis Spatholobis, 125 parts of Fructus Crataegis, 120 parts, Rhizoma Curcumae Longae, 120 parts of Radix Ginsengs, 110 parts of Rhizoma Sparganii, 105 parts of Stigma Crocis, 105 parts of Radix Paeoniae Rubra, 100 parts of Rhizoma Polygonatis, 95 parts of Ramulus Cinnamomi, 88 parts of Pericarpium Citri Reticulataes, 88 parts, Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 86 parts of Herba Cistanches, 85 parts of Lignum Dalbergiae Odoriferaes, 85 parts of Radix Rhodiolaes, 84 parts of Rhizoma Acori Graminei, 70 parts of Oletum Trogopteroris, 55 parts of Rhizoma Polygonati Odorati, 60 parts of Radix Notoginseng, 40 parts of Radix Et Rhizoma Rhei, 8 parts of Borneolum Syntheticums.
As preferably: 265 parts of Radix Salviae Miltiorrhizaes, 255 parts of the Radixs Astragali, 140 parts of Rhizoma Corydalis, 140 parts of Rhizoma Chuanxiongs, 138 parts of Radix Curcumaes, 128 parts of Radix Ophiopogonis, 120 parts of Caulis Spatholobis, 120 parts of Fructus Crataegis, 125 parts, Rhizoma Curcumae Longae, 125 parts of Radix Ginsengs, 105 parts of Rhizoma Sparganii, 110 parts of Stigma Crocis, 108 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Polygonatis, 95 parts of Ramulus Cinnamomi, 86 parts of Pericarpium Citri Reticulataes, 86 parts, Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 89 parts of Herba Cistanches, 90 parts of Lignum Dalbergiae Odoriferaes, 90 parts of Radix Rhodiolaes, 80 parts of Rhizoma Acori Graminei, 65 parts of Oletum Trogopteroris, 60 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 40 parts of Radix Et Rhizoma Rhei, 10 parts of Borneolum Syntheticums.
As preferably: 250 parts of Radix Salviae Miltiorrhizaes, 260 parts of the Radixs Astragali, 135 parts of Rhizoma Corydalis, 135 parts of Rhizoma Chuanxiongs, 140 parts of Radix Curcumaes, 125 parts of Radix Ophiopogonis, 129 parts of Caulis Spatholobis, 129 parts of Fructus Crataegis, 124 parts, Rhizoma Curcumae Longae, 124 parts of Radix Ginsengs, 108 parts of Rhizoma Sparganii, 106 parts of Stigma Crocis, 110 parts of Radix Paeoniae Rubra, 110 parts of Rhizoma Polygonatis, 100 parts of Ramulus Cinnamomi, 90 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 88 parts of Radix Angelicae Sinensis, 88 parts of Herba Cistanches, 80 parts of Lignum Dalbergiae Odoriferaes, 80 parts of Radix Rhodiolaes, 85 parts of Rhizoma Acori Graminei, 68 parts of Oletum Trogopteroris, 58 parts of Rhizoma Polygonati Odorati, 58 parts of Radix Notoginseng, 45 parts of (processed with wine) Radix Et Rhizoma Rhei, 9 parts of Borneolum Syntheticums.
As preferably: 255 parts of Radix Salviae Miltiorrhizaes, 260 parts of the Radixs Astragali, 138 parts of Rhizoma Corydalis, 138 parts of Rhizoma Chuanxiongs, 138 parts of Radix Curcumaes, 130 parts of Radix Ophiopogonis, 120 parts of Caulis Spatholobis, 129 parts of Fructus Crataegis, 125 parts, Rhizoma Curcumae Longae, 122 parts of Radix Ginsengs, 106 parts of Rhizoma Sparganii, 108 parts of Stigma Crocis, 110 parts of Radix Paeoniae Rubra, 100 parts of Rhizoma Polygonatis, 90 parts of Ramulus Cinnamomi, 88 parts of Pericarpium Citri Reticulataes, 86 parts, Radix Glycyrrhizae, 88 parts of Radix Angelicae Sinensis, 88 parts of Herba Cistanches, 90 parts of Lignum Dalbergiae Odoriferaes, 90 parts of Radix Rhodiolaes, 80 parts of Rhizoma Acori Graminei, 67 parts of Oletum Trogopteroris, 56 parts of Rhizoma Polygonati Odorati, 58 parts of Radix Notoginseng, 44 parts of (processed with wine) Radix Et Rhizoma Rhei, 9 parts of Borneolum Syntheticums.
A Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, is characterized in that, comprises described Chinese medicine.
A Chinese medicinal pill for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, is characterized in that, comprises described Chinese medicine and Mel, and mass ratio is 1:0.5 ~ 1.5.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine and solvent.
In this Chinese medicine preparation, described solvent is rice wine, and by mass percentage, the proportioning of itself and Chinese medicine is 1:8 ~ 10.
In this Chinese medicine preparation, described solvent is yellow wine, and by mass percentage, the proportioning of itself and Chinese medicine is 1:5 ~ 10.
In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine is 1:1 ~ 6.
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease of the present invention, has the effects such as QI invigorating blood stasis dispelling, promoting the circulation of QI to relieve pain, cures mainly Qi deficiency blood stasis type angina pectoris (coronary heart disease), and obvious effective rate is nearly 100%, and cure rate is about 90%.This Chinese medicine, considering, on the basis of each constituent content, to have optimized the proportioning of Radix Ginseng and Oletum Trogopterori, has improved the effect of QI invigorating blood stasis dispelling.Although this Chinese medicine is formed by several kinds of Chinese medicinal materials compatibility, it cures mainly clearly, has no side effect.Meanwhile, diabetes and the metabolic arthritis that can bring out coronary atherosclerotic heart disease can be alleviated or cure to this Chinese medicine.
The specific embodiment
For the present invention is more clearly described, first summarize the scheme of some treatment coronary atherosclerotic heart diseases that prior art provides.Background technology part has explained, no longer describes in detail.Patent, patent application and other documents that the application directly quotes, include this case in as a reference, and the part that other do not do to express, with reference to known technology.
Existing patent documentation discloses the document of multiple treatment coronary atherosclerotic heart diseases.
201110048251.3(102119971B) relate to a kind of Chinese medicine for the treatment of coronary heart disease, it comprises Ramulus Persicae 1-3 part, Herba Potentillae Discoloris 1-3 part, Moschus 0.5-1 part, Pemisetum flaccidum Griseb. 2-5 part, Herba Plantaginis 1-3 part and anistree 0.5-1 part.Coronary heart disease differentiation of symptoms and signs for classification of syndrome complexity, same component is difficult for all types of coronary heart disease for the treatment of.
Treat coronary heart disease 201310342311.1 relate to one, anginal medicine, Flos Carthami 20-60g, the white 20-60g of a round bamboo basket, Radix Platycodonis 10-30g, Rhizoma Acori Graminei 5-15g, Ramulus Cinnamomi 10-30g, Rhizoma Corydalis 10-20g, Fructus Trichosanthis 30-100g, Herba Potentillae Discoloris 10-30g, Moschus 10-30g, Radix Aucklandiae 10-30g, Semen Platycladi 20-60g, Caulis Spatholobi 10-30g, Radix Ophiopogonis 10-30g, Herba Plantaginis 20-60g, Radix Puerariae 10-30g, Rhizoma Curculiginis 10-20g, Oletum Trogopterori 10-30g, Semen Persicae 10-20g, Radix Polygalae 20-60g, Semen Lepidii (Semen Descurainiae) 10-30g, big gun first 5-15g, Fructus Toosendan 5-15g, Rhizoma Zingiberis 5-15g, Radix Glycyrrhizae Preparata 10-30g.
201210541518.7 relate to a kind of Chinese medicine composition for angina pectoris, are prepared from by the traditional Chinese medicinal composition raw materials of following weight proportion: Rhizoma Corydalis 220-260 part, Moschus 4-12 part, Styrax 4-12 part, Rhizoma Chuanxiong 100-140 part, Radix Ginseng 100-140 part, Borneolum Syntheticum 6-18 part.Borneolum Syntheticum GUIXIN, liver, can control blood stasis.Borneolum Syntheticum is poisonous, should limit its intake.
201110453345.9 disclose a kind of Chinese medicine composition for the treatment of angina pectoris, and it is by Radix Codonopsis, the Radix Astragali, Fructus Mori, Rhizoma Chuanxiong, Radix Curcumae, Oletum Trogopterori, Flos Rosae Rugosae, Semen Litchi and Lignum Aquilariae Resinatum.Radix Codonopsis, the Radix Astragali, Fructus Mori, Rhizoma Chuanxiong, Radix Curcumae, Oletum Trogopterori are the good medicine for the treatment of qi stagnation and blood stasis type coronary heart disease.
201110174824.7 relate to a kind of medicine for the treatment of coronary heart disease, it has optimized the proportioning of American ginseng total saponins and tetrahydropalmatine.
201110155727.3 relate to the Chinese medicine for the treatment of coronary heart disease, and it comprises 25～50 parts, Radix Rehmanniae Preparata, 10～25 parts of Fructus Corni, 15～30 parts of Herba Cistanches, 5～20 parts of gun additioners, 5～15 parts of Radix Ginsengs, 15～25 parts of Radix Ophiopogonis, 2.5～10 parts of Fructus Schisandrae Chinensis, 5～15 parts of Ramulus Cinnamomi, 5～10 parts, Radix Glycyrrhizae, 10～25 parts of Radix Angelicae Sinensis, 15～50 parts of the Radixs Astragali, 15～50 parts of Radix Salviae Miltiorrhizaes, 1.5～5 parts, Lignum Santali Albi, 5～10 parts of Fructus Amomis, 5～15 parts of Rhizoma Chuanxiongs, 10～20 parts of Fructus Crataegis, 15～25 parts of Flos Lonicerae, 15～25 parts of Radix Scrophulariaes, 15～50 parts, the Radix Rehmanniae.This case is treated all types of coronary heart disease with same component.
Although ancient Chinese medicine has the saying of " Radix Ginseng fear Oletum Trogopterori ", modern TCM research shows, in rational proportioning or reasonably under solvent action, people participates in Oletum Trogopterori compatibility can treat various diseases.For example, " Radix Ginseng, the experimentation of Oletum Trogopterori compatibility to the effect of A549 human lung adenocarcinoma cell line " (Traditional Chinese Medicinal College of Liaoning. Wang Jin), the chemical substance basic research of Oletum Trogopterori " Radix Ginseng fear " (time precious traditional Chinese medical science traditional Chinese medicines. ring D etc. makes a whistling sound), " Radix Ginseng join Oletum Trogopterori " mutual restraint between two drugs " simple analysis " Liu Yuchun etc., and " the modern study progress of Radix Ginseng, Oletum Trogopterori compatibility " (Chinese Chinese medicine magazine. Li Lian Jun etc.) all this is done careful research.Certainly, the proportion compatibility that people participates in Oletum Trogopterori has to consider the impact of other compositions in prescription, such as Radix Salviae Miltiorrhizae, the Radix Astragali etc.Existing patent documentation also discloses the patent scheme of some ginseng compatibility's Oletum Trogopteroris.Consider other components in prescription, in this application, Radix Ginseng: Oletum Trogopterori is 120 ~ 125:65 ~ 70.
01131203.3(1124153B) disclose a kind of medicinal composition for restoring cardiac collaterals, be used for the treatment of angina pectoris.It Radix Ginseng, Radix Codonopsis, Radix Pseudostellariae, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Rhizoma Dioscoreae that comprises Rational Dosage clinically wherein one or more, Hirudo, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Flos Carthami, Radix Paeoniae Rubra, Lignum Dalbergiae Odoriferae, Radix Notoginseng, Radix Curcumae, Semen Persicae, Rhizoma Corydalis, Eupolyphaga Seu Steleophaga, Olibanum, Sanguis Draxonis, Myrrha, Caulis Spatholobi, Lignum Aquilariae Resinatum, Rhizoma Curcumae, Rhizoma Sparganii, Herba Leonuri, Oletum Trogopterori, Radix Achyranthis Bidentatae, Fructus Trichosanthis, the Rhizoma Pinelliae, Bulbus Allii Macrostemonis, Semen Armeniacae Amarum, Fructus Aurantii, Fructus Aurantii Immaturus, Lignum Santali Albi, Rhizoma Cyperi, the Radix Aucklandiae, Pericarpium Citri Reticulatae, Radix Platycodonis, Rhizoma Corydalis, Radix Polygoni Multiflori, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Radix Ophiopogonis, Rhizoma Polygonati, Borneolum Syntheticum, Rhizoma Acori Graminei, Semen Ziziphi Spinosae, Radix Polygalae, succinum, Herba Asari, Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi, Herba Epimedii, Fructus Schisandrae Chinensis, Fructus Crataegi, Radix Puerariae, Poria, the Radix Angelicae Dahuricae, Radix Bupleuri, Pheretima, wherein one or more and Scorpio of Rhizoma Gastrodiae, Periostracum Cicadae, Scolopendra is the combination preparation of one or more wherein.The specific embodiments of this case is more, and each component all has the effect of blood circulation promoting and blood stasis dispelling, but whether all can be used for treating angina pectoris, needs empirical research.
200810127216.9 relate to a kind of medicated wine for the treatment of coronary heart disease, and it comprises Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Fructus Crataegi, Radix Ginseng, Cortex Cinnamomi, Radix Angelicae Sinensis, Cordyceps, Flos Carthami, Rhizoma Chuanxiong, Vascular aurantii, Herba Saussureae Involueratae, Radix Notoginseng, Oletum Trogopterori and sticky rice wine.In this case, people participates in Oletum Trogopterori equivalent.
200810127966.6 disclose a kind of method for the treatment of swine coronary diseases with traditional Chinese medicines, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Fructus Crataegi, Radix Ginseng, Cortex Cinnamomi, Radix Angelicae Sinensis, Cordyceps, Flos Carthami, Rhizoma Chuanxiong, Vascular aurantii, Herba Saussureae Involueratae, Radix Notoginseng, Oletum Trogopterori.In this case, Radix Ginseng is less than Oletum Trogopterori.It is said, this component can be used for the treatment of swine coronary diseases.
200910234765.0 relate to a kind of Chinese medicine for the treatment of swine coronary diseases, are made up of 20 grams of 40 grams of Semen Cassiaes, 50 grams of Radix Salviae Miltiorrhizaes, 20 grams of the Rhizoma Anemarrhenaes, 30 grams of Fructus Crataegis, 10 grams of Radix Ginsengs, 20 grams of Radix Paeoniae Rubra, 20 grams of Radix Angelicae Sinensis, 20 grams of Cordyceps, 20 grams, Flos Carthami, 20 grams of Rhizoma Chuanxiongs, 20 grams, Semen Persicae, 20 grams of Herba Saussureae Involuerataes, 40 grams of Herba Leonuris, 50 grams of Radix Notoginseng, Oletum Trogopterori.In this case, the quantity of Radix Ginseng is less than Oletum Trogopterori.
200910019636.X relates to a kind of Chinese medicine composition for the treatment of palace blood and preparation method thereof, and it comprises Radix Ginseng, the Radix Astragali, Cortex Phellodendri, Carapax et Plastrum Testudinis, Radix Scutellariae, Fructus Rosae Laevigatae, the Radix Paeoniae Alba, Radix Polygoni Multiflori Preparata, Radix Glycyrrhizae Preparata, Radix Angelicae Sinensis, Rhizoma Cyperi, gun ginger, Radix Rehmanniae Preparata, Chinese mugwort charcoal, the Rhizoma Atractylodis Macrocephalae and cyrtomium rhizome charcoal.Radix Ginseng, the Radix Astragali, Radix Glycyrrhizae and Radix Angelicae Sinensis etc. are the good medicine for the treatment of qi depression to blood stasis.
201010263713.9 disclose a kind of medicine for the treatment of coronary heart disease and preparation method thereof, in this case people to participate in the proportioning of Oletum Trogopterori be 1 ~ 20:1 ~ 20.Oletum Trogopterori contains the composition that reduces Radix Ginseng effect, and people participates in Oletum Trogopterori at large ratio range compatibility, may reduce effect or have side effects.
201210537333.9 1 kinds of menorrheal Chinese medicine compositions for the treatment of, are made up of the each raw material of following weight portion: 20～40 parts of Radix Ginsengs, 20～40 parts of the Radixs Astragali, 10～20 parts of the Rhizoma Atractylodis Macrocephalaes, 3～9 parts of Radix Glycyrrhizae Preparatas, 3～9 parts of Rhizoma Cimicifugaes, 5～15 parts, Colla Corii Asini, 10～20 parts, the Radix Rehmanniae, 8～15 parts of Pollen Typhaes, 10～30 parts of Herba Leonuris, 5～15 parts of Oletum Trogopteroris, 3～9 parts of Radix Notoginseng, 3～9 parts, Radix Rubiae.In this Chinese medicinal components, Radix Ginseng is about two to four times of Oletum Trogopterori.
201010288583.4 disclose a kind of Chinese medicine preparation for the treatment of femur head necrosis, comprising: Radix Polygoni Multiflori Preparata 10-20 part, Radix Rehmanniae Preparata 10-20 part, Radix Angelicae Sinensis 10-15 part, Colla Corii Asini 10-15 part, Radix Paeoniae Alba 10-20 part, Radix Ginseng 5-10 part, Radix Codonopsis 10-20 part, Radix Pseudostellariae 10-20 part, Radix Astragali 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Rhizoma Dioscoreae 10-20 part, Olibanum 10-15 part, Myrrha 10-15 part, Rhizoma Corydalis 10-15 part, Oletum Trogopterori 10-15 part.This case is treated femur head necrosis in the mode of blood circulation promoting and blood stasis dispelling, nourishing the liver and kidney.
201310468625.6 disclose a kind of formula of Radix Ginseng activating blood circulation to dissipate blood stasis wine, comprise Radix Ginseng 20-35 part, Rhizoma Corydalis 10-30 part, Concha Arcae 10-30 part, Radix Rubiae 10-30 part, Thallus Laminariae (Thallus Eckloniae) 10-30 part, Semen Raphani 10-30 part, wide art 10-30 part, Exocarpium Citri Rubrum 10-30 part, Oletum Trogopterori 10-30 part, Herba Lycopi 10-30 part, Rhizoma Sparganii 10-30 part, Lignum Sappan 10-30 part, Hirudo 10-30 part, Radix Achyranthis Bidentatae 10-30 part, Rhizoma Curcumae Longae 10-30 part, Caulis Hederae Sinensis 10-30 part, Flos Rosae Chinensis 10-30 part.In this case, the content of Radix Ginseng is slightly larger than Oletum Trogopterori.
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease of the present invention, according to the mass fraction, consist of the following composition: 250 ~ 265 parts of Radix Salviae Miltiorrhizaes, 250 ~ 260 parts of the Radixs Astragali, 135 ~ 145 parts of Rhizoma Corydalis, 135 ~ 145 parts of Rhizoma Chuanxiongs, 135 ~ 140 parts of Radix Curcumaes, 125 ~ 130 parts of Radix Ophiopogonis, 120 ~ 129 parts of Caulis Spatholobis, 120 ~ 129 parts of Fructus Crataegis, 120 ~ 125 parts, Rhizoma Curcumae Longae, 120 ~ 125 parts of Radix Ginsengs, 105 ~ 110 parts of Rhizoma Sparganii, 105 ~ 110 parts of Stigma Crocis, 105 ~ 110 parts of Radix Paeoniae Rubra, 90 ~ 110 parts of Rhizoma Polygonatis, 90 ~ 100 parts of Ramulus Cinnamomi, 86 ~ 90 parts of Pericarpium Citri Reticulataes, 86 ~ 89 parts, Radix Glycyrrhizae, 86 ~ 89 parts of Radix Angelicae Sinensis, 86 ~ 89 parts of Herba Cistanches, 80 ~ 90 parts of Lignum Dalbergiae Odoriferaes, 80 ~ 90 parts of Radix Rhodiolaes, 80 ~ 85 parts of Rhizoma Acori Graminei, 65 ~ 70 parts of Oletum Trogopteroris, 55 ~ 60 parts of Rhizoma Polygonati Odorati, 55 ~ 60 parts of Radix Notoginseng, 40 ~ 45 parts of Radix Et Rhizoma Rhei, 8 ~ 10 parts of Borneolum Syntheticums.
Pharmacology: Radix Salviae Miltiorrhizae can blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia.The Radix Astragali is longer than tonifying Qi and lifting yang, promote the production of body fluid and nourish blood, can with ginseng compatibility.Rhizoma Corydalis can be invigorated blood circulation, circulation of qi promoting, pain relieving.Radix Ophiopogonis can YIN nourishing and the production of body fluid promoting, and lung moistening clears away heart-fire.Rhizoma Chuanxiong can blood-activating and qi-promoting, wind-expelling pain-stopping.Rhizoma Polygonati can boosting qi and nourishing yin, spleen invigorating, lung moistening, kidney tonifying.Caulis Spatholobi returns liver, kidney channel, can blood circulation promoting and enriching, and menstruction regulating and pain relieving, Chang Peiwu benefiting QI for activating blood circulation dredging collateral medicine, as medicines such as the Radix Astragali, Radix Salviae Miltiorrhizae, Pheretimas.The Fructus Crataegi QI and blood of passing through, has the merit of promoting blood circulation to disperse blood clots and relieves pain, with Rhizoma Chuanxiong, Semen Persicae with using.Control the stagnant chest and hypochondrium of the stasis of blood, normal and Rhizoma Chuanxiong, Semen Persicae, Flos Carthami are equal to use.Radix Ginseng can strongly invigorating primordial QI.Rhizoma Sparganii is returned liver, spleen channel, removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.Rhizoma Curcumae and Rhizoma Sparganii Chang Xiangxu are use, and so Rhizoma Sparganii is partial to removing blood stasis, and Rhizoma Curcumae is partial to dispelling the stagnated QI.Stigma Croci can removing blood stasis, promoting the circulation of blood and blood, tune blood, and strength is better than Flos Carthami.Radix Paeoniae Rubra is returned Liver Channel, can clearing away heat and cooling blood, and eliminating stasis to stop pain.Ramulus Cinnamomi GUIXIN, lung meridian, can supporing yang activating QI, and promoting blood circulation, only palpitates from nervousness, can be with Radix Ginseng, Radix Ophiopogonis and Radix Glycyrrhizae with using.Pericarpium Citri Reticulatae has Xin Hangwen logical, have promoting the circulation of QI to relieve pain, spleen invigorating and in merit.Radix Glycyrrhizae can coordinating the actions of various ingredients in a prescription, with the invigorating the spleen and replenishing QI such as Radix Ginseng, Radix Astragali medicine compatibility, for the card of deficiency-weakness of spleen-QI.Radix Angelicae Sinensis can be enriched blood and be invigorated blood circulation, menstruction regulating and pain relieving.Herba Cistanches can reinforcing the kidney and supporting YANG, loosening bowel to relieve constipation.Lignum Dalbergiae Odoriferae can fall apart and can manage it, energy blood stasis dispelling regulating QI to relieve pain, and the available breast side of body trusted subordinate pain of controlling stagnation of QI and blood, is equal to use with Oletum Trogopterori, Rhizoma Chuanxiong.Radix Rhodiolae can invigorating the spleen and benefiting QI, clearing away lung-heat to relieve cough, blood circulation promoting and blood stasis dispelling.Rhizoma Acori Graminei GUIXIN warp, the beneficial will of can allaying excitement.Oletum Trogopterori can promoting blood circulation and stopping pain, and removing stasis to stop bleeding, specially enters Liver Channel blood system, is good at promoting blood circulation, removing blood stasis and relieving pain, normal with Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae with use.Rhizoma Polygonati Odorati can nourishing YIN to relieve dryness, and promoting the production of body fluid to quench thirst, associated with Radix Ophiopogonis.Radix Notoginseng can dissipating blood stasis hemostasis, subduing swelling and relieving pain, the same use of compatibility blood-activating and qi-moving medicinal, the merit of the analgesic therapy of invigorating blood circulation is more outstanding.Radix Et Rhizoma Rhei has the blood circulation and removing stasis effect of stimulating the menstrual flow, and is the common drug for the treatment of blood stasis symptom, should processed with wine.Borneolum Syntheticum GUIXIN, spleen, lung meridian, the refreshment of having one's ideas straightened out, clearing away heat to alleviate pain, unsuitable decoction.
Above pharmacology is observed herbal medicine efficacy and the combination principle of " Chinese Pharmacopoeia " (version in 2010) and " Chinese materia medica " (New Century higher institutions of Chinese medicine teaching material).But herbal pharmacology is profound, the summary of above pharmacology is not the whole pharmacology of the present invention.We are formed by multi-medicament compatibility, and combined effect, should not distinguish monarch.
embodiment mono-
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, consist of the following composition: Radix Salviae Miltiorrhizae 25.0g, Radix Astragali 25.0g, Rhizoma Corydalis 13.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 13.5g, Radix Ophiopogonis 13.0g, Caulis Spatholobi 12.5g, Fructus Crataegi 12.5g, Rhizoma Curcumae Longae 12.0g, Radix Ginseng 12.0g, Rhizoma Sparganii 11.0g, Stigma Croci 11.0g, Radix Paeoniae Rubra 10.5g, Rhizoma Polygonati 10.0g, Ramulus Cinnamomi 9.5g, Pericarpium Citri Reticulatae 8.8g, Radix Glycyrrhizae 8.8g, Radix Angelicae Sinensis 8.6g, Herba Cistanches 8.6g, Lignum Dalbergiae Odoriferae 8.6g, Radix Rhodiolae 8.6g, Rhizoma Acori Graminei 8.6g, Oletum Trogopterori 7.0g, Rhizoma Polygonati Odorati 6.0g, Radix Notoginseng 6.0g, Radix Et Rhizoma Rhei 4.0g, Borneolum Syntheticum 0.9g.Can divide two doses, every day, potion, took for every dose at twice.
Treat a Chinese medicinal pill for Qi deficiency blood stasis type coronary atherosclerotic heart disease, comprise described Chinese medicine composition and Mel, mass ratio is 1: ~ 1.5.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is rice wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:8.
embodiment bis-
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, consist of the following composition: Radix Salviae Miltiorrhizae 26.0g, Radix Astragali 25.0g, Rhizoma Corydalis 13.5g, Rhizoma Chuanxiong 14.5g, Radix Curcumae 13.5g, Radix Ophiopogonis 13.0g, Caulis Spatholobi 12.5g, Fructus Crataegi 12.5g, Rhizoma Curcumae Longae 12.0g, Radix Ginseng 12.0g, Rhizoma Sparganii 11.0g, Stigma Croci 10.5g, Radix Paeoniae Rubra 10.5g, Rhizoma Polygonati 10.0g, Ramulus Cinnamomi 9.5g, Pericarpium Citri Reticulatae 8.8g, Radix Glycyrrhizae 8.8g, Radix Angelicae Sinensis 8.6g, Herba Cistanches 8.6g, Lignum Dalbergiae Odoriferae 8.5g, Radix Rhodiolae 8.5g, Rhizoma Acori Graminei 8.4g, Oletum Trogopterori 7.0g, Rhizoma Polygonati Odorati 5.5g, Radix Notoginseng 6.0g, Radix Et Rhizoma Rhei 4.0g, Borneolum Syntheticum 0.8g.Can divide two doses, every day, potion, took for every dose at twice.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:3.
embodiment tri-
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, consist of the following composition: Radix Salviae Miltiorrhizae 26.5g, Radix Astragali 25.5g, Rhizoma Corydalis 14.0g, Rhizoma Chuanxiong 14.0g, Radix Curcumae 13.8g, Radix Ophiopogonis 12.8g, Caulis Spatholobi 12.0g, Fructus Crataegi 12.0g, Rhizoma Curcumae Longae 12.5g, Radix Ginseng 12.5g, Rhizoma Sparganii 10.5g, Stigma Croci 11.0g, Radix Paeoniae Rubra 10.8g, Rhizoma Polygonati 9.0g, Ramulus Cinnamomi 9.5g, Pericarpium Citri Reticulatae 8.6g, Radix Glycyrrhizae 8.6g, Radix Angelicae Sinensis 8.9g, Herba Cistanches 8.9g, Lignum Dalbergiae Odoriferae 9.0g, Radix Rhodiolae 9.0g, Rhizoma Acori Graminei 8.0g, Oletum Trogopterori 6.5g, Rhizoma Polygonati Odorati 6.0g, Radix Notoginseng 5.5g, Radix Et Rhizoma Rhei 4.0g, Borneolum Syntheticum 1.0g.Can divide two doses, every day, potion, took for every dose at twice.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:6.
embodiment tetra-
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, consist of the following composition: Radix Salviae Miltiorrhizae 25.0g, Radix Astragali 26.0g, Rhizoma Corydalis 13.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 14.0g, Radix Ophiopogonis 12.5g, Caulis Spatholobi 12.9g, Fructus Crataegi 12.9g, Rhizoma Curcumae Longae 12.4g, Radix Ginseng 12.4g, Rhizoma Sparganii 10.8g, Stigma Croci 10.6g, Radix Paeoniae Rubra 11.0g, Rhizoma Polygonati 11.0g, Ramulus Cinnamomi 100g, Pericarpium Citri Reticulatae 9.0g, Radix Glycyrrhizae 8.9g, Radix Angelicae Sinensis 8.8g, Herba Cistanches 8.8g, Lignum Dalbergiae Odoriferae 8.0g, Radix Rhodiolae 8.0g, Rhizoma Acori Graminei 8.5g, Oletum Trogopterori 6.8g, Rhizoma Polygonati Odorati 5.8g, Radix Notoginseng 5.8g, (processed with wine) Radix Et Rhizoma Rhei 4.5g, Borneolum Syntheticum 0.9g.Can divide two doses, every day, potion, took for every dose at twice.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:1.
embodiment five
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, consist of the following composition: Radix Salviae Miltiorrhizae 25.5g, Radix Astragali 26.0g, Rhizoma Corydalis 13.8g, Rhizoma Chuanxiong 13.8g, Radix Curcumae 13.8g, Radix Ophiopogonis 13.0g, Caulis Spatholobi 12.0g, Fructus Crataegi 12.9g, Rhizoma Curcumae Longae 12.5g, Radix Ginseng 12.2g, Rhizoma Sparganii 10.6g, Stigma Croci 10.8g, Radix Paeoniae Rubra 11.0g, Rhizoma Polygonati 10.0g, Ramulus Cinnamomi 9.0g, Pericarpium Citri Reticulatae 8.8g, Radix Glycyrrhizae 8.6g, Radix Angelicae Sinensis 8.8g, Herba Cistanches 8.8g, Lignum Dalbergiae Odoriferae 9.0g, Radix Rhodiolae 9.0g, Rhizoma Acori Graminei 8.0g, Oletum Trogopterori 6.7g, Rhizoma Polygonati Odorati 5.6g, Radix Notoginseng 5.8g, (processed with wine) Radix Et Rhizoma Rhei 4.4g, Borneolum Syntheticum 0.9g.Can divide two doses, every day, potion, took for every dose at twice.
A Chinese medicinal pill for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, is characterized in that, comprises described Chinese medicine composition and Mel, and mass ratio is 1:1.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is yellow wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:10.
embodiment six
The Chinese medicine for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, consist of the following composition: Radix Salviae Miltiorrhizae 26.5g, Radix Astragali 25.0g, Rhizoma Corydalis 13.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 13.5g, Radix Ophiopogonis 13.0g, Caulis Spatholobi 12.5g, Fructus Crataegi 12.5g, Rhizoma Curcumae Longae 12.0g, Radix Ginseng 12.5g, Rhizoma Sparganii 11.0g, Stigma Croci 10.5g, Radix Paeoniae Rubra 10.5g, Rhizoma Polygonati 10.0g, Ramulus Cinnamomi 9.4g, Pericarpium Citri Reticulatae 8.8g, Radix Glycyrrhizae 8.8g, Radix Angelicae Sinensis 8.6g, Herba Cistanches 8.6g, Lignum Dalbergiae Odoriferae 8.8g, Radix Rhodiolae 8.5g, Rhizoma Acori Graminei 8.4g, Oletum Trogopterori 7.2g, Rhizoma Polygonati Odorati 5.7g, Radix Notoginseng 6.0g, Radix Et Rhizoma Rhei 4.0g, Borneolum Syntheticum 0.8g.Can divide two doses, every day, potion, took for every dose at twice.
A Chinese medicinal pill for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, is characterized in that, comprises described Chinese medicine composition and Mel, and mass ratio is 1:0.5.
Treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is rice wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:10.
The consumption of each Chinese medicinal components of above embodiment does not represent potion consumption, in practical operation, generally divides two daily.The application does not limit the preparation method of this Chinese medicine composition, according to Chinese Pharmacopoeia, prepares, takes according to usual method.Certainly, according to experimental demonstration, Radix Ginseng and Oletum Trogopterori adopt aqueous solution or the drinks of concentration of alcohol more than 40%, and three hours at a simmer, edible with other component compatibilities, effect was better.
Typical case
1, the high Fengzhen king in Ruichang City, Jiangxi Province X, while work, chest pain is uncomfortable in chest lowerly, rest mitigation symptoms, weak breathing hard, cardiopalmus is perspired.On inspection, it suffers from coronary heart disease with qi deficiency and blood stasis, and main clinical manifestation is angina pectoris.In addition, it suffers from diabetes for a long time, and coronary heart disease may be relevant therewith.Adopt we's treatment many half a year, coronary heart disease is without recurrence, and diabetes take a turn for the better.
2, the refined XXX that occupies of Ruichang City, Jiangxi Province basin city limitless blessing, the retired staff of government, chest pain is uncomfortable in chest, weak breathes hard, and dark tongue quality, by ecchymosis, through the inspection of institute of traditional Chinese medicine of city, is diagnosed as typical coronary heart disease with qi deficiency and blood stasis, and clinical manifestation is angina pectoris.But through treatment by Chinese herbs in 2 years, without taking a turn for the better.Adopt after we, be clearly better, whether recur, need further to be observed.
3, Xunyang District, Jiujiang City of Jiangxi Province grandson X, five teen ages, obesity.Suffer from for a long time hyperlipidemia and angina pectoris, Chinese medical discrimination type is typical blood stasis due to qi deficiency.Adopt the incremental treatment of we, keep on a diet simultaneously, more than a year without recurrence.
Each Chinese medicinal components of above embodiment can be used for the treatment of coronary atherosclerotic heart disease, especially effective to Qi deficiency blood stasis type angina pectoris, and it is to the effective percentage 100% take blood stasis due to qi deficiency as main angina pectoris, and cure rate is about 90%.Also effective in cure for the diabetes of Coronary Artery Disease Complicated, metabolic arthritis, hyperlipidemia etc., cure rate is about 50%.
Claims (9)
1. treat the Chinese medicine of Qi deficiency blood stasis type coronary atherosclerotic heart disease for one kind, it is characterized in that, according to the mass fraction, consist of the following composition: 250 ~ 265 parts of Radix Salviae Miltiorrhizaes, 250 ~ 260 parts of the Radixs Astragali, 135 ~ 145 parts of Rhizoma Corydalis, 135 ~ 145 parts of Rhizoma Chuanxiongs, 135 ~ 140 parts of Radix Curcumaes, 125 ~ 130 parts of Radix Ophiopogonis, 120 ~ 129 parts of Caulis Spatholobis, 120 ~ 129 parts of Fructus Crataegis, 120 ~ 125 parts, Rhizoma Curcumae Longae, 120 ~ 125 parts of Radix Ginsengs, 105 ~ 110 parts of Rhizoma Sparganii, 105 ~ 110 parts of Stigma Crocis, 105 ~ 110 parts of Radix Paeoniae Rubra, 90 ~ 110 parts of Rhizoma Polygonatis, 90 ~ 100 parts of Ramulus Cinnamomi, 86 ~ 90 parts of Pericarpium Citri Reticulataes, 86 ~ 89 parts, Radix Glycyrrhizae, 86 ~ 89 parts of Radix Angelicae Sinensis, 86 ~ 89 parts of Herba Cistanches, 80 ~ 90 parts of Lignum Dalbergiae Odoriferaes, 80 ~ 90 parts of Radix Rhodiolaes, 80 ~ 85 parts of Rhizoma Acori Graminei, 65 ~ 70 parts of Oletum Trogopteroris, 55 ~ 60 parts of Rhizoma Polygonati Odorati, 55 ~ 60 parts of Radix Notoginseng, 40 ~ 45 parts of Radix Et Rhizoma Rhei, 8 ~ 10 parts of Borneolum Syntheticums.
2. Chinese medicine according to claim 1, it is characterized in that, consist of the following composition: 260 parts of Radix Salviae Miltiorrhizaes, 250 parts of the Radixs Astragali, 135 parts of Rhizoma Corydalis, 145 parts of Rhizoma Chuanxiongs, 135 parts of Radix Curcumaes, 130 parts of Radix Ophiopogonis, 125 parts of Caulis Spatholobis, 125 parts of Fructus Crataegis, 120 parts, Rhizoma Curcumae Longae, 120 parts of Radix Ginsengs, 110 parts of Rhizoma Sparganii, 105 parts of Stigma Crocis, 105 parts of Radix Paeoniae Rubra, 100 parts of Rhizoma Polygonatis, 95 parts of Ramulus Cinnamomi, 88 parts of Pericarpium Citri Reticulataes, 88 parts, Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 86 parts of Herba Cistanches, 85 parts of Lignum Dalbergiae Odoriferaes, 85 parts of Radix Rhodiolaes, 84 parts of Rhizoma Acori Graminei, 70 parts of Oletum Trogopteroris, 55 parts of Rhizoma Polygonati Odorati, 60 parts of Radix Notoginseng, 40 parts of Radix Et Rhizoma Rhei, 8 parts of Borneolum Syntheticums.
3. Chinese medicine according to claim 1, it is characterized in that, consist of the following composition: 265 parts of Radix Salviae Miltiorrhizaes, 255 parts of the Radixs Astragali, 140 parts of Rhizoma Corydalis, 140 parts of Rhizoma Chuanxiongs, 138 parts of Radix Curcumaes, 128 parts of Radix Ophiopogonis, 120 parts of Caulis Spatholobis, 120 parts of Fructus Crataegis, 125 parts, Rhizoma Curcumae Longae, 125 parts of Radix Ginsengs, 105 parts of Rhizoma Sparganii, 110 parts of Stigma Crocis, 108 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Polygonatis, 95 parts of Ramulus Cinnamomi, 86 parts of Pericarpium Citri Reticulataes, 86 parts, Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 89 parts of Herba Cistanches, 90 parts of Lignum Dalbergiae Odoriferaes, 90 parts of Radix Rhodiolaes, 80 parts of Rhizoma Acori Graminei, 65 parts of Oletum Trogopteroris, 60 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 40 parts of Radix Et Rhizoma Rhei, 10 parts of Borneolum Syntheticums.
4. Chinese medicine according to claim 1, it is characterized in that, consist of the following composition: 250 parts of Radix Salviae Miltiorrhizaes, 260 parts of the Radixs Astragali, 135 parts of Rhizoma Corydalis, 135 parts of Rhizoma Chuanxiongs, 140 parts of Radix Curcumaes, 125 parts of Radix Ophiopogonis, 129 parts of Caulis Spatholobis, 129 parts of Fructus Crataegis, 124 parts, Rhizoma Curcumae Longae, 124 parts of Radix Ginsengs, 108 parts of Rhizoma Sparganii, 106 parts of Stigma Crocis, 110 parts of Radix Paeoniae Rubra, 110 parts of Rhizoma Polygonatis, 100 parts of Ramulus Cinnamomi, 90 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 88 parts of Radix Angelicae Sinensis, 88 parts of Herba Cistanches, 80 parts of Lignum Dalbergiae Odoriferaes, 80 parts of Radix Rhodiolaes, 85 parts of Rhizoma Acori Graminei, 68 parts of Oletum Trogopteroris, 58 parts of Rhizoma Polygonati Odorati, 58 parts of Radix Notoginseng, 45 parts of (processed with wine) Radix Et Rhizoma Rhei, 9 parts of Borneolum Syntheticums.
5. Chinese medicine according to claim 1, it is characterized in that, consist of the following composition: 255 parts of Radix Salviae Miltiorrhizaes, 260 parts of the Radixs Astragali, 138 parts of Rhizoma Corydalis, 138 parts of Rhizoma Chuanxiongs, 138 parts of Radix Curcumaes, 130 parts of Radix Ophiopogonis, 120 parts of Caulis Spatholobis, 129 parts of Fructus Crataegis, 125 parts, Rhizoma Curcumae Longae, 122 parts of Radix Ginsengs, 106 parts of Rhizoma Sparganii, 108 parts of Stigma Crocis, 110 parts of Radix Paeoniae Rubra, 100 parts of Rhizoma Polygonatis, 90 parts of Ramulus Cinnamomi, 88 parts of Pericarpium Citri Reticulataes, 86 parts, Radix Glycyrrhizae, 88 parts of Radix Angelicae Sinensis, 88 parts of Herba Cistanches, 90 parts of Lignum Dalbergiae Odoriferaes, 90 parts of Radix Rhodiolaes, 80 parts of Rhizoma Acori Graminei, 67 parts of Oletum Trogopteroris, 56 parts of Rhizoma Polygonati Odorati, 58 parts of Radix Notoginseng, 44 parts of (processed with wine) Radix Et Rhizoma Rhei, 9 parts of Borneolum Syntheticums.
6. a Chinese medicinal capsule for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, is characterized in that, comprises Chinese medicine composition as described in claim 1 to 5 any one.
7. a Chinese medicinal pill for the treatment of Qi deficiency blood stasis type coronary atherosclerotic heart disease, is characterized in that, comprises Chinese medicine composition and Mel as described in claim 1 to 5 any one, and mass ratio is 1:0.5 ~ 1.5.
8. treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising Chinese medicine composition and solvent as described in claim 1 to 5 any one, wherein, described solvent is rice wine, yellow wine or ethanol.
9. treat a Chinese medicine preparation for Qi deficiency blood stasis type coronary atherosclerotic heart disease, it is characterized in that comprising Chinese medicine composition and solvent as described in claim 1 to 5 any one, wherein, in described solvent, contain mass fraction and be 40% to 90% ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410059637.8A CN103784888A (en) | 2014-02-23 | 2014-02-23 | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410059637.8A CN103784888A (en) | 2014-02-23 | 2014-02-23 | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103784888A true CN103784888A (en) | 2014-05-14 |
Family
ID=50661225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410059637.8A Pending CN103784888A (en) | 2014-02-23 | 2014-02-23 | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103784888A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103990004A (en) * | 2014-06-11 | 2014-08-20 | 任新年 | Traditional Chinese medicinal liquor for treating coronary heart disease and preparation method thereof |
| CN105168653A (en) * | 2015-09-10 | 2015-12-23 | 徐银祯 | Traditional Chinese medicine composition used for treating coronary heart disease |
| CN105943901A (en) * | 2016-05-10 | 2016-09-21 | 青岛市第三人民医院 | Traditional Chinese medicinal preparation for treating chest congestion after heart bypass |
| CN108744260A (en) * | 2018-06-27 | 2018-11-06 | 南阳市中心医院 | A kind of Cardiological medicated physical treatment device |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
| CN114404547A (en) * | 2022-01-24 | 2022-04-29 | 上海中医药大学附属曙光医院 | Ointment formula for strengthening body resistance and removing blood stasis and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872315A (en) * | 2005-06-01 | 2006-12-06 | 天津天士力制药股份有限公司 | Application of medication of containing spatholobus stem in resistant medication anti aspirin |
| CN1895620A (en) * | 2006-06-13 | 2007-01-17 | 杨万彬 | Chinese-medicinal composition for treating coronary heart disease |
| CN101406630A (en) * | 2008-11-27 | 2009-04-15 | 董军芳 | Medicament for treating coronary heart disease |
| CN102228525A (en) * | 2011-06-27 | 2011-11-02 | 陈伯明 | Traditional Chinese medicine for treating cardio-cerebral vascular stagnation |
| CN103463568A (en) * | 2013-09-12 | 2013-12-25 | 张永雷 | Traditional Chinese medicine for treating coronary heart disease |
-
2014
- 2014-02-23 CN CN201410059637.8A patent/CN103784888A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872315A (en) * | 2005-06-01 | 2006-12-06 | 天津天士力制药股份有限公司 | Application of medication of containing spatholobus stem in resistant medication anti aspirin |
| CN1895620A (en) * | 2006-06-13 | 2007-01-17 | 杨万彬 | Chinese-medicinal composition for treating coronary heart disease |
| CN101406630A (en) * | 2008-11-27 | 2009-04-15 | 董军芳 | Medicament for treating coronary heart disease |
| CN102228525A (en) * | 2011-06-27 | 2011-11-02 | 陈伯明 | Traditional Chinese medicine for treating cardio-cerebral vascular stagnation |
| CN103463568A (en) * | 2013-09-12 | 2013-12-25 | 张永雷 | Traditional Chinese medicine for treating coronary heart disease |
Non-Patent Citations (3)
| Title |
|---|
| 曲淑兰: ""人参、五灵脂合用治疗胸痹体会"", 《中国中医药信息杂志》 * |
| 鲁耀邦等: ""人参五灵脂配伍对急性血瘀和气虚血瘀大鼠血液流变学的影响"", 《中国中西医结合杂志》 * |
| 黄素芳等: ""治疗冠心病中药使用频率的研究分析"", 《中药新药与临床药理》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103990004A (en) * | 2014-06-11 | 2014-08-20 | 任新年 | Traditional Chinese medicinal liquor for treating coronary heart disease and preparation method thereof |
| CN105168653A (en) * | 2015-09-10 | 2015-12-23 | 徐银祯 | Traditional Chinese medicine composition used for treating coronary heart disease |
| CN105943901A (en) * | 2016-05-10 | 2016-09-21 | 青岛市第三人民医院 | Traditional Chinese medicinal preparation for treating chest congestion after heart bypass |
| CN108744260A (en) * | 2018-06-27 | 2018-11-06 | 南阳市中心医院 | A kind of Cardiological medicated physical treatment device |
| CN108744260B (en) * | 2018-06-27 | 2020-10-02 | 南阳市中心医院 | Intracardiac branch of academic or vocational study medicine physiotherapy device |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
| CN114404547A (en) * | 2022-01-24 | 2022-04-29 | 上海中医药大学附属曙光医院 | Ointment formula for strengthening body resistance and removing blood stasis and application thereof |
| CN114404547B (en) * | 2022-01-24 | 2022-12-20 | 上海中医药大学附属曙光医院 | Body resistance strengthening and blood stasis removing cream formula and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN103784888A (en) | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis | |
| CN103230548B (en) | Traditional Chinese medicine composition for treating pulmonary heart disease | |
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| CN108478731A (en) | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease | |
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN112843207A (en) | Formula and preparation method of smearing type thermal moxibustion ointment | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN100563705C (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN103211980B (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN104288496A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
| CN100337678C (en) | Chinese traditional medicine with hemorrhoid resolving, poison expelling and stagnation expelling functions | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN104225507A (en) | Chinese medicine for treating limb paralysis and pain caused by cerebral hemorrhage | |
| CN103893724A (en) | Traditional Chinese medicine composition for treating liver depression and spleen deficiency type idiopathic edema of women | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN102451458A (en) | Traditional Chinese medicine formula for treating chronic pyelonephritis | |
| CN105126022A (en) | Medicine for treating ichthyosis and preparation method of medicine | |
| CN105169338A (en) | Medicine composition for treating female climacteric syndromes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140514 |